ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on Twitter

Kidney Week

Abstract: TH-PO957

COVID-19 Infection in Patients Receiving Kidney Replacement Therapy Under Universal Health Coverage in Thailand

Session Information

Category: Coronavirus (COVID-19)

  • 000 Coronavirus (COVID-19)

Authors

  • Changsirikulchai, Siribha, Division of Nephrology, Department of Medicine, Srinakharinwirot University, Nakhonnayok, Thailand
  • Sangthawan, Pornpen, Division of Nephrology, Department of Medicine, Faculty of Medicine, Prince of Songkla University, Songkla, Thailand
  • Ingviya, Thammasin, Deparment of Family and Preventive Medicine, Faculty of Medicine, Prince of Songkla University, Songkla, Thailand
Background

The Thai nation has used public health and social health measures to control the spreading of COVID-19 pandemic infection since February 2020. The sample of these measures was identifying the index cases, tracing cases with high-risk contacts, isolating in quarantine sites, vaccination, using face masks, washing hands, and physical distancing. Patients with high mortality risk from COVID-19 would be treated in hospitals. This study aimed to evaluate the incidence and outcomes of COVID- 19 infection in patients receiving kidney replacement therapy (KRT) under universal health coverage (UC).

Methods

Data of patients who registered with the National Health Security Office Region 4 (NHSO4) to receive peritoneal dialysis (PD), hemodialysis (HD), or kidney transplantation (KT) during January 2020-December 2021 was analyzed. The incidence and mortality rates of COVID -19 in each type of KRT were calculated. The comorbidities and complications which were recorded in the file of the electronic claim to reimburse from the NHSO4 were diagnosed following the ICD-10. The comorbidities and complications which were the risks associated with death in COVID-19 were analyzed. The cost of treatment according to the Diagnosis Related Group (DRG) which was paid back to the hospitals from the NHSO was evaluated.

Results

There were 1,744 patients on PD, 1,267 patients on HD, and 35 patients on KT. The incidence, mortality rate, and characteristics of patients with COVID-19 infection in each category of KRT were shown in Table 1.

Conclusion

The incidence of COVID-19 infection was highest in patients receiving HD followed by KT and PD respectively. The cost of treatment according to DRG in patients with PD was lower than in those with HD. The mortality was not different among these types of KRT.